Cancer progression and response to current therapies is associated with select members of the microbiota. However, how and why the microbiota impacts the anti-tumor immune response is unknown. Our lab is investigating how the microbiota-specific immune response (specifically bacteria-specific T cells) impacts anti-tumor immunity in colorectal cancer.